Search Results

There are 56244 results for: content related to: Monoclonal antibodies in the treatment of multiple myeloma

  1. You have free access to this content
    Chimeric Antigen Receptor (CAR) therapy for multiple myeloma

    British Journal of Haematology

    Volume 172, Issue 5, March 2016, Pages: 685–698, Djordje Atanackovic, Sabarinath V. Radhakrishnan, Neelam Bhardwaj and Tim Luetkens

    Version of Record online : 20 JAN 2016, DOI: 10.1111/bjh.13889

  2. You have free access to this content
    Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo

    British Journal of Haematology

    Volume 149, Issue 4, May 2010, Pages: 537–549, Kihyun Kim, Sun-Young Kong, Mariateresa Fulciniti, Xianfeng Li, Weihua Song, Sabikun Nahar, Peter Burger, Mathew J. Rumizen, Klaus Podar, Dharminder Chauhan, Teru Hideshima, Nikhil C. Munshi, Paul Richardson, Ann Clark, Janet Ogden, Andreas Goutopoulos, Luca Rastelli, Kenneth C. Anderson and Yu-Tzu Tai

    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08127.x

  3. You have free access to this content
    Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma

    European Journal of Haematology

    Volume 90, Issue 6, June 2013, Pages: 441–468, Alessandro Allegra, Giuseppa Penna, Andrea Alonci, Sabina Russo, Bruna Greve, Vanessa Innao, Viviana Minardi and Caterina Musolino

    Version of Record online : 17 APR 2013, DOI: 10.1111/ejh.12107

  4. You have free access to this content
    Development of target-specific treatments in multiple myeloma

    British Journal of Haematology

    Volume 151, Issue 1, October 2010, Pages: 3–15, Asher A. Chanan-Khan, Ivan Borrello, Kelvin P. Lee and Donna E. Reece

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1365-2141.2010.08262.x

  5. You have free access to this content
    Lenalidomide in multiple myeloma: current experimental and clinical data

    European Journal of Haematology

    Volume 88, Issue 4, April 2012, Pages: 279–291, Mauro Cives, Annalisa Milano, Franco Dammacco and Franco Silvestris

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1600-0609.2011.01735.x

  6. You have free access to this content
    MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

    British Journal of Haematology

    Volume 169, Issue 3, May 2015, Pages: 333–343, Parisa Asvadi, Andrew Cuddihy, Rosanne D. Dunn, Vivien Jiang, Mae X. Wong, Darren R. Jones, Tiffany Khong and Andrew Spencer

    Version of Record online : 3 FEB 2015, DOI: 10.1111/bjh.13298

  7. You have free access to this content
    Immunotherapy of cancer in 2012

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 309–335, John M. Kirkwood, Lisa H. Butterfield, Ahmad A. Tarhini, Hassane Zarour, Pawel Kalinski and Soldano Ferrone

    Version of Record online : 10 MAY 2012, DOI: 10.3322/caac.20132

  8. Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma

    British Journal of Haematology

    Volume 175, Issue 3, November 2016, Pages: 448–456, María-Victoria Mateos, Miguel Granell, Albert Oriol, Joaquin Martinez-Lopez, Joan Blade, Miguel T. Hernandez, Jesus Martín, Mercedes Gironella, Mark Lynch, Eric Bleickardt, Prashni Paliwal, Anil Singhal and Jesus San-Miguel

    Version of Record online : 19 JUL 2016, DOI: 10.1111/bjh.14263

  9. You have free access to this content
    Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settings

    British Journal of Haematology

    Volume 154, Issue 6, September 2011, Pages: 755–762, Paul G. Richardson, Jacob Laubach, Constantine S. Mitsiades, Robert Schlossman, Teru Hideshima, Katherine Redman, Dharminder Chauhan, Irene M. Ghobrial, Nikhil Munshi and Kenneth C. Anderson

    Version of Record online : 7 JUL 2011, DOI: 10.1111/j.1365-2141.2011.08791.x

  10. Current status of new drugs for the treatment of patients with multiple myeloma

    Internal Medicine Journal

    Volume 36, Issue 12, December 2006, Pages: 781–789, M. Kenealy and 1 H. M. Prince 1,2

    Version of Record online : 9 NOV 2006, DOI: 10.1111/j.1445-5994.2006.01218.x

  11. You have free access to this content
    CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder

    International Journal of Urology

    Volume 20, Issue 2, February 2013, Pages: 251–255, Jung-Woo Choi, Younghye Kim, Ju-Han Lee and Young-Sik Kim

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1442-2042.2012.03128.x

  12. You have free access to this content
    Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma

    British Journal of Haematology

    Volume 163, Issue 4, November 2013, Pages: 478–486, Jonathan L. Kaufman, Ruben Niesvizky, Edward A. Stadtmauer, Asher Chanan-Khan, David Siegel, Heather Horne, William A. Wegener and David M. Goldenberg

    Version of Record online : 25 SEP 2013, DOI: 10.1111/bjh.12565

  13. Newly developed effective anti-cancer drugs targeting multiple myeloma

    Drug Development Research

    Volume 69, Issue 7, November 2008, Pages: 451–459, Daniel Man-Yuen Sze, Jian Hou and Lily Zhou

    Version of Record online : 23 DEC 2008, DOI: 10.1002/ddr.20275

  14. You have free access to this content
    Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

    British Journal of Haematology

    Volume 171, Issue 1, October 2015, Pages: 52–59, David H. Vesole, Elizabeth Bilotti, Joshua R. Richter, Ann McNeill, Laura McBride, Laura Raucci, Palka Anand, Urszula Bednarz, Kristin Ivanovski, Judith Smith, Veena Batra, Adolfo Aleman, Taliah Sims, Laura Guerrero, Anthony Mato and David S. Siegel

    Version of Record online : 27 MAY 2015, DOI: 10.1111/bjh.13517

  15. You have free access to this content
    Cancer immunotherapy: Progress and challenges in the clinical setting

    European Journal of Immunology

    Volume 41, Issue 6, June 2011, Pages: 1510–1515,

    Version of Record online : 26 MAY 2011, DOI: 10.1002/eji.201190035

  16. Development of Immunonconjugates for in Vivo Delivery: Cancer Diagnosis, Imaging, and Therapy

    Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

    Yashwant Pathak, Simon Benita, Pages: 57–81, 2012

    Published Online : 23 APR 2012, DOI: 10.1002/9781118229019.ch4

  17. You have free access to this content
    Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma

    British Journal of Haematology

    Volume 132, Issue 4, February 2006, Pages: 385–397, Hiroshi Yasui, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson

    Version of Record online : 29 NOV 2005, DOI: 10.1111/j.1365-2141.2005.05860.x

  18. Monoclonal antibody proteomics: Discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step

    ELECTROPHORESIS

    Volume 28, Issue 23, No. 23 December 2007, Pages: 4401–4406, Eszter Csanky, Petra Olivova, Eva Rajnavolgyi, William Hempel, Nadege Tardieu, Elesne Toth Katalin, Anne Jullien, Carole Malderez-Bloes, Mariana Kuras, Manuel X. Duval, Laszlo Nagy, Beata Scholtz, William Hancock, Barry Karger, András Guttman and Laszlo Takacs

    Version of Record online : 26 NOV 2007, DOI: 10.1002/elps.200700256

  19. Evidence of rotavirus AU32 like G9 strains from nontypeable fecal specimens of Indian children hospitalized during 1993–1994

    Journal of Medical Virology

    Volume 74, Issue 4, December 2004, Pages: 656–661, Pinki S. Awachat and Shobhana D. Kelkar

    Version of Record online : 13 OCT 2004, DOI: 10.1002/jmv.20227

  20. A Murine Monoclonal Antibody to Glycogen: Characterization of Epitope-Fine Specificity by Saturation Transfer Difference (STD) NMR Spectroscopy and Its Use in Mycobacterial Capsular α-Glucan Research

    ChemBioChem

    Volume 16, Issue 6, April 13, 2015, Pages: 977–989, Robert van de Weerd, Dr. M. Alvaro Berbís, Marrion Sparrius, Janneke J. Maaskant, Maikel Boot, Nanne J. Paauw, Nadine de Vries, Dr. Louis Boon, Dr. Otto Baba, Prof. Dr. F. Javier Cañada, Dr. Jeroen Geurtsen, Prof. Dr. Jesús Jiménez-Barbero and Dr. Ben J. Appelmelk

    Version of Record online : 12 MAR 2015, DOI: 10.1002/cbic.201402713